Showing results (281-290 of 2,337) with videos related to
Sort By:
Pageof 234
Clinical Lung Cancer|September 15, 2005
Targeting multiple signal transduction pathways in lung cancerAlex A AdjeiClinical Lung Cancer|August 8, 2007
Dual inhibition: combining epidermal growth factor-targeted therapies in non-small-cell lung cancerCheryl Ho, Angela Davies, Philip Mack, et al.Clinical Lung Cancer|February 22, 2007
Phase II trial of neoadjuvant chemotherapy using alternating doublets in non-small-cell lung cancerRenato G Martins, Rodrigo Dienstmann, Paulo de Biasi, et al.Clinical Lung Cancer|February 22, 2007
A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734Michael C Perry, Leslie J Kohman, James A Bonner, et al.Clinical Lung Cancer|March 27, 2007
Chemotherapy and antiangiogenic agents in non-small-cell lung cancerLeora Horn, Alan SandlerClinical Lung Cancer|January 24, 2007
Non-rash skin toxicities associated with novel targeted therapiesMario E Lacouture, Scott A Boerner, Patricia M LorussoClinical Lung Cancer|January 24, 2007
Gemcitabine/carboplatin in a modified 21-day administration schedule for advanced-stage non-small-cell lung cancerMana Yoshimura, Fumio Imamura, Kiyonobu Ueno, et al.Clinical Lung Cancer|January 24, 2007
Response to erlotinib in first-line treatment of non-small-cell lung cancer in a white male smoker with squamous-cell histologyMichaela Achille, Marielle Gallegos-Ruiz, Giuseppe Giaccone, et al.Clinical Lung Cancer|June 13, 2006
Second-line treatment for advanced-stage non-small-cell lung cancer: current and future optionsCheryl Ho, Angela M Davies, Primo N Lara, et al.Clinical Lung Cancer|June 13, 2006
Neglected and underrepresented subpopulations: elderly and performance status 2 patients with advanced-stage non-small-cell lung cancerCorey J LangerPageof 234